Background: The pathophysiology of femoroacetabular impingement (FAI) remains to be better understood, including factors affecting symptom development and disease progression.
Osteoarthritis of the hip is a common and disabling condition in the United States that is associated with everincreasing health care costs and societal burden. 9, 21 Over the past decade, there has been a remarkable paradigm shift in the understanding of prearthritic hip disease, with a major emphasis on early detection and preventive treatment for the younger patient. Most important has been the recognition of femoroacetabular impingement (FAI) as a potential major etiologic factor in prearthritic hip dysfunction and subsequent premature osteoarthritis. 5 FAI occurs as a result of abnormal bony morphology of the proximal femur and/or acetabulum that leads to repetitive abutment of the femur and acetabulum with hip flexion and rotational activities. The most common form of FAI is known as cam-type impingement, which results from a femoral-sided deformity. Cam-type impingement is commonly caused by asphericity of the anterolateral femoral head and may result in labral tears and chondromalacia as this femoral prominence contacts the acetabular-sided structures during activities. Pincer-type impingement occurs secondary to overcoverage of the anterosuperior acetabular rim because of focal overcoverage, acetabular retroversion, or global overcoverage. Patients with symptomatic FAI experience hip pain, diminished hip function, activity restriction, and reduced quality of life. 3 In some cases, clinical symptoms worsen and premature hip degeneration ensues. 5, 15 Abnormal femoral bony anatomy consistent with FAI has a prevalence of 4% to 25% in the general population, although only a portion of these ever develop hip pain. 1, 6, 7 The athletic population appears to have an even higher prevalence of bony FAI deformity, 20 with 70% of professional ice hockey players having a cam deformity according to 1 study. 12 Similarly, the radiographic definitions of pincertype FAI continue to evolve, and there is increased recognition that some parameters (eg, positive crossover sign) can occur as normal variants. 11, 16, 19 Despite the recent advances in understanding and treating of FAI, significant controversy persists regarding the natural history of FAI and the risk factors for disease progression. The contralateral hip represents an opportunity to observe this natural history in a high-risk population for the development of hip symptoms, secondary to patient-specific factors that may have played a role in the development of symptoms in the ipsilateral hip. The contralateral extremity has been a valuable model for the natural history of various orthopaedic conditions. 14, 23 In addition, the risk of developing a symptomatic contralateral hip is valuable prognostic information for an elite athlete who is contemplating secondary surgery and return to play.
The purpose of the current study was to determine rates of symptom development in the contralateral hip among patients with FAI and to identify predictors of the development of these symptoms over time.
METHODS
A cohort of 195 consecutive patients undergoing hip preservation surgery for symptomatic and idiopathic FAI (cam or combined cam/pincer) was prospectively enrolled in a research database of a single surgeon from January 31, 2011, to December 31, 2013. Institutional review board approval was obtained before initiation of this study. The hip that was not receiving surgery (contralateral hip) was the focus of this study. Exclusion criteria included contralateral hips that had 1 of the following: previous hip surgery, significant evidence of radiographic osteoarthritis (Tönnis osteoarthritis grade 2) at baseline, or a history of childhood hip disorder (eg, Legg-Calvé-Perthes disease or slipped capital femoral epiphysis).
Bony morphology of the contralateral hip was assessed with standing anteroposterior (AP) pelvis and 45°Dunn radiographs obtained according to standardized protocols. 2 Incomplete imaging resulted in the exclusion of 16 patients (8%), leaving 179 patients. All patients had failed a minimum 3-month nonoperative treatment trial before surgical intervention. At the preoperative visit, clinical information was recorded, including history, physical examination findings, sports participation, and patient-rated outcome measures, such as the modified Harris Hip Score and UCLA (University of California, Los Angeles) activity score. Pain in the contralateral hip was assessed at baseline and each follow-up time point according to the pain component of the modified Harris Hip Score specific to each hip. Routine follow-up for these patients typically occurred at 1, 2, and 5 years after the surgical intervention on the initially symptomatic hip or at any clinical visit occurring during this period. When clinical follow-up was not completed, phone follow-up and mailed questionnaire packets were utilized (6 cases, 4%).
At baseline and postoperative follow-up time points, patients recorded standardized outcome questionnaires, Figure 1 . Demonstration of the anteroposterior and 45º Dunn radiographic views as well as the primary radiographic measurements made. Head-neck offset ratio is calculated as the ratio of head-neck offset to femoral head diameter. including the presence of symptoms in the contralateral hip. Pain was characterized as none, slight, mild, moderate, severe, or disabling. Significant symptoms necessitated the presence of at least moderate pain, while none, mild, or slight pain was not included. Patients developing symptoms in the contralateral hip were subclassified as having symptoms at presentation (initial symptoms) or developing symptoms during the follow-up period (developed symptoms).
Alpha angle of Nötzli et al 22 and head-neck offset ratio (HNOR) were measured on 45°Dunn and AP pelvis radiographs to characterize the severity of the femoral cam morphology ( Figure 1 ). Additionally, the lateral center edge angle (LCEA) and acetabular inclination (AI) were assessed on AP pelvis radiographs. The presence of a positive crossover sign, LCEA 40°, or AI \0°was assessed as a marker of pincer morphology. Radiographic measurements were made with the OsiriX MD viewer (Pixmeo) and Orthopaedic Studio plug-in (Spectronic) by a single reader using de-identified radiographs. Intraobserver reliability was assessed by comparing the reader's measurements made on a subset of 20 patients during 2 separate occasions, 2 weeks apart. Accuracy of radiographic measurements was determined with intraclass correlation coefficients (ICCs) for continuous measurements. ICCs were calculated with a 2-way random model for single measurement with absolute testing. Intraobserver agreement was moderate to very high in measurement of alpha angle on the AP and 45°Dunn views (ICCs: 0.67 and 0.91, respectively). Intraobserver agreement was high to very high in measurement of HNOR on the AP and 45°Dunn views (ICCs: 0.80 and 0.90, respectively). The inter-and intraobserver reliability of the LCEA, AI, and crossover sign was previously established. 18 All patients with a minimum follow-up of at least 1 year after presentation were included in the current study. The time to symptom development in the contralateral hip was recorded, with a time of zero indicating symptom presence in the contralateral hip at initial completion of the questionnaire. Symptom development in the contralateral hip was not considered during the initial 6 weeks of the perioperative period.
Statistics
The study cohort was characterized with standard descriptive statistics. Univariate analysis was used to determine factors significantly associated with symptom development in the group that was initially asymptomatic. KaplanMeier survival analysis was performed for symptom development in the contralateral hip as a function of time in years. A P value \.05 was considered significant.
RESULTS
A total of 148 patients (83%) were followed for at least 1 year after enrollment (mean, 2.9 years; range, 1.0-6.6 years) and composed the final cohort. The study cohort had a mean age of 30.9 years (65.2% female). The mean alpha angles of the contralateral hip on AP pelvis and 45°Dunn views were 66.4°and 61.5°, respectively.
Thirty-four patients (23%) had initial symptoms in the contralateral hip. Figure 2 summarizes the frequency of initial symptoms and the development of symptoms over time for the entire cohort. A majority of patients (n = 114, 77%) did not report significant symptoms in the contralateral hip at presentation. Twenty-seven hips (24% of the initially asymptomatic) developed symptoms during the follow-up period at a mean 2.0 years (SD = 1.28 years) from presentation. Table 1 compares the subgroup of patients who developed symptoms over the course of the study and those who remained asymptomatic. Sixteen (11%) patients underwent contralateral hip procedures during the follow-up period, including 35% of those with symptoms at presentation and 15% of those who developed symptoms since presentation. The percentage of male patients did not significantly differ between symptomatic and asymptomatic groups (51.9% vs 34.5%, respectively; P = .105). HNOR on the AP pelvis radiograph was significantly lower among hips that developed symptoms (0.153 vs 0.163 asymptomatic group, P = .027). Maximum alpha angle (either AP or Dunn) was not predictive of the development of symptoms during this time frame (72.7°symptomatic vs 70.3°asymp-tomatic, P = .503). The LCEA (P = .978) and crossover sign (P = .865) were not associated with the development of symptoms. Similarly, an LCEA 40°or AI \0°(each P .999) was not associated with symptom development. Patients with a UCLA activity score of 9 or 10 at presentation were less prevalent in the symptomatic group (18.2% vs 43.8% asymptomatic group, P = .032). The mean hip internal rotation in 90°of flexion for hips developing symptoms was 10.7°, as opposed to 14.3°among hips remaining asymptomatic (P = .096). The total arc of rotation in flexion (internal rotation in 90°of flexion 1 external rotation in flexion) was significantly decreased among hips developing symptoms (39.4°vs 50.4°asymptomatic, P = .012).
Progress to Surgery
Kaplan-Meier survival analysis (Figure 3 ) demonstrates the percentage of patients who remained symptom-free at specified time intervals. At 1, 2, 3, and 4 years, 72%, 67%, 56%, and 48% of all patients remained asymptomatic in the contralateral hip, respectively.
DISCUSSION
The natural history of FAI remains to be better defined. Structural abnormalities predisposing to symptomatic FAI commonly affect both hips, although they may be associated with symptoms in only 1 hip at the time of presentation. The prognosis of the contralateral hip is largely unknown. Athletes with bilateral deformity who have already had surgery in 1 hip often inquire about their risk of contralateral FAI symptoms. Prognosis of the contralateral hip may affect timing of interventions and, in the case of professional athletes, can affect contract decisions and livelihood. The current study investigated the frequency of short-term symptom development (mean, 2.9; range, 1.0-6.6 years) in the contralateral hip for patients who have unilateral symptoms from FAI. Patient-specific factors such as radiographic deformity, range of motion, and activity level were found to influence the onset of symptoms.
Patient-specific factors affecting symptom development in FAI have not yet been well characterized. In a retrospective study of 113 patients with symptomatic FAI in 1 hip, Allen et al 1 looked at the contralateral hip and found a 78% prevalence of contralateral cam deformity; however, only 26% of those patients were symptomatic at presentation. The authors found that an alpha angle .60°(on the Dunn lateral projection) increased the chances of having a symptomatic lesion. They did not correlate symptom development with patient factors other than radiographic deformity. In another retrospective review of .600 patients over a 2-year period, Klingenstein et al 10 compared a cohort of patients receiving bilateral (staged) FAI surgery with those undergoing primary unilateral FAI surgery. In a multivariate logistic regression model, younger age, male sex, higher alpha angles, and decreased acetabular anteversion were associated with higher risk of bilateral surgery. These studies are limited by the inability to account for symptoms among individuals who do not undergo surgery (or who do undergo surgery but outside the study institution or time frame). The cross-sectional nature of both these studies does not allow for evaluation of symptom development over time.
In our study, we examined radiographic and clinical data for patients who had an unaffected hip but went on to develop symptoms. Note that this cohort does not represent the ''general'' population, as these patients are at increased risk for developing symptomatic FAI in the contralateral hip by virtue of having the disease in the other hip. However, given the high-risk nature of our cohort, we see symptomatic ''events'' at a higher rate, which improves ease of study and characterization. These findings are at least applicable to patients with known FAI in the other hip and still may have important implications for the general population.
We found that structural anomalies in the femurspecifically, a lack of head-neck offset (represented by decreased HNOR)-was a risk factor for developing symptoms in our cohort. Ito et al 8 used radial-cut magnetic resonance imaging to characterize the femoral neck of symptomatic patients with FAI and determined that decreased head-neck offset in the anterolateral aspect of the femur was commonly seen among those with labral damage. This seems to be a separate clinical deformity from the aspherical femoral head (as measured by the alpha angle), although both are implicated in cam-type impingement. The aforementioned studies examining the contralateral hip of patients with FAI did not measure HNOR, although both did find that an increasing alpha angle was a risk factor for bilateral disease, with the Allen et al 1 study citing a cutoff of 60°. We did not find alpha angle to be a significant determinant of symptom development in this cohort. It is possible that our study was not powered to make this determination and that the HNOR simply has a larger effect size and was more visible in a smaller cohort over a shorter time frame. It is also possible that our study population, for unspecified reasons, had more severe deformities (alpha angles averaging .70°) such that any effect attributed to a small difference between cohorts is relatively muted. Additionally, parameters of pincer-type morphology, including LCEA, AI, and crossover sign, showed no association with symptom development.
Dynamic hip mechanics are thought to play a role in FAI deformity, although the exact mechanisms are debated. This study demonstrated that a lower activity level and a decreased range of motion in 90°of flexion can be risk factors for bilateral symptom development. Range of motion in flexion is thought to be limited by the bony anatomy of the hip joint, which includes (but is not limited to) femoral head deformity, femoral neck offset, and femoral version, as well as acetabular coverage and version. Therefore, a patient's range of motion before abutment of the femur and acetabulum may be a reasonable surrogate for judging whether his or her anatomy, as a whole, predisposes to developing FAI. Our results would support this reasoning, as those patients with more limited motion were at risk for symptomatic progression. Similarly, we expected that increased athletic demands on the hip would also predispose to FAI symptoms, as those patients would be more likely to reach the extremes of motion that the hip joint allows. Instead, we found that high activity levels at presentation were protective of contralateral hip symptom development. It may be that the conditioning of the hip is improved for these patients, which can deter the onset of symptoms through mechanisms that we do not fully understand. Another theory is that there is a subgroup of less-active patients who have subclinical dysfunction of the contralateral hip that is masked by their inactivity and then later exposed once their symptomatic disease is addressed.
Despite the advantages and novelty of these findings, this study has several limitations. The short-term nature of the follow-up (1-6.6 years) makes the current study only preliminary in regard to the ultimate status of the contralateral hip. Longer-term follow-up would be useful for monitoring progression to future hip surgery or hip osteoarthritis. Additionally, we included moderate symptoms in the primary analysis, rather than including minimal or slight symptoms. These milder symptoms may resolve or indeed progress to worse symptoms at later time points. The relatively small numbers of patients with symptoms at early time points result in the current study's being underpowered for some comparisons and inadequate for multivariate statistical analysis. Finally, there are limitations attributed to our radiographic analysis techniques. Adequate visualization and measurement of proximal femoral abnormalities is dependent on radiographic technique and location of a particular morphology. 2, 19 AP pelvis radiographs will better visualize morphologic changes located on the lateral femoral neck, whereas lateral views (eg, the frog lateral) offer superior visualization of the anterior femoral neck. 4 The 45°Dunn radiograph, with a position between these extremes, was shown to offer the best visualization of cam morphology in the characteristic anterolateral neck location and correlated well with computed tomography imaging. 13, 17 Given the readily available AP and 45°Dunn views of the contralateral hip for a symptomatic hip, we are able to characterize morphology in the most common locations in the contralateral hip. We also chose to focus on femoral-sided morphology with our analysis and did not include patients who had an isolated pincer mechanism. Primarily, we believe that pure pincer deformity represents a smaller subgroup of overall patients with FAI who may have different risk factors for progression than those with cam FAI; thus, we chose to not study them together. In addition, consistent characterization of pincer morphology is made difficult by variations in pelvic position and technique, which would further complicate analysis.
The current study prospectively investigated the development of symptoms in the contralateral hip of patients with symptomatic FAI who were undergoing surgical intervention. Approximately 23% of patients reported moderate contralateral symptoms at the time of presentation. Over the following 4 years, an additional 29% (total 52%) developed moderate contralateral symptoms. Patients with higher activity levels, a larger arc of motion in flexion, and increased offset (HNOR) as measured on AP pelvis radiographs were less likely to develop symptoms during the study period. These results can assist both the clinician and the patient with short-and midterm prognostic information and may facilitate treatment decision making for the contralateral asymptomatic hip. Further research into the associated risk factors could offer insight into the pathophysiology of symptom development as well as inform prevention strategies.
